PM

Philip Morris International Inc.

Fundamental data last updated:August 4, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Consumer Defensive

industry

Tobacco

Exchange

NYSE

County of HQ

US

Next Earnings Date

Pending Announcement

Business Summary

Philip Morris International Inc. functions as a prominent tobacco enterprise, actively working toward a smoke-free future. The company is strategically diversifying its long-term product range to incorporate items beyond traditional tobacco and nicotine. Its primary business involves both conventional cigarettes and an expanding array of smoke-free alternatives, such as innovative heat-not-burn devices, vapor products, and oral nicotine solutions. These offerings are distributed in markets worldwide, with the exception of the United States. The smoke-free portfolio includes brands like HEETS (encompassing Creations, Dimensions, Marlboro variants), Parliament HeatSticks, and TEREA, in addition to KT&G-licensed brands Fiit and Miix. For conventional cigarettes, the company sells internationally recognized brands such as Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris. Regionally, it also owns major cigarette brands like Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia, and Fortune and Jackpot in the Philippines. PMI's smoke-free innovations are currently available across 71 global markets. Established in 1987, Philip Morris International Inc. is headquartered in New York, New York.

 


VALUATION

P/E

26.02

Market Cap ($M USD)

$287.96B

Forward P/E

15.08

PEG

0.21

PRICE TO SALES

6.94

PRICE TO BOOK

-31.12

EV / EBITDA

18.73

5-Year Average P/E

Free Cash Flow Yield

3.70%

DCF Value

$203.84

Graham Number

N/A

Price to FCF

27.00

EV to FCF

31.36

Earnings Yield

3.84%

FCF Yield

3.70%

DIVIDEND

Yield

3.18%

Annual Payout

$5.88

Payout Ratio

79.44%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$7.10

Next Year EPS Growth Estimate

$12.25

Next Year Revenue Growth Estimate

$52.98B

Return on Equity (ROE)

-105.29%

FREE CASH FLOW

Operating Margin

36.83%

Debt-to-Equity

-4.89

Piotroski F-Score

7

Altman Z-Score

4.34

Return on Invested Capital (ROIC)

35.80%

Current Ratio

0.98

Quick Ratio

0.54

Net Debt to EBITDA

2.60

Interest Coverage

9.65

Gross Profit margin

67.30%

FCF PER SHARE

$6.82

REVENUE PER SHARE

$26.55

Gainseekers Quantitative Analysis

Summary

Philip Morris International Inc. presents a compelling valuation story. Based on the data at the time of this analysis, the stock traded below its DCF value, suggesting potential undervaluation. The Forward P/E of 14.77 indicates a more attractive entry point compared to its current P/E, hinting at expected earnings growth. With an Altman Z-score of 4.29, the company appears financially robust, reducing bankruptcy risk. However, the negative Price/Book ratio raises questions about asset valuation, demanding a closer look at its balance sheet.

AI Exposure / Tech Reliance

Operating in the tobacco industry, Philip Morris is less directly impacted by AI and tech shifts compared to tech-centric sectors. However, its ability to leverage data analytics for consumer insights and operational efficiencies could enhance its competitive edge. The company's focus on reduced-risk products also aligns with modern tech-driven health trends.

The Bull Case

For the value-driven investor, Philip Morris shines with a robust ROIC of 35.80%, indicating exceptional capital efficiency. The Piotroski F-Score of 7 suggests solid financial health, while a strong FCF Yield of 3.78% underscores its ability to generate cash. Coupled with a high gross profit margin of 67.30%, the company demonstrates significant pricing power and operational prowess, making it a tempting buy for those seeking growth at a reasonable price.

The Bear Case

Despite its strengths, Philip Morris faces structural challenges. The Price/Sales ratio of 6.79 and EV to EBITDA of 18.39 suggest a premium valuation, potentially limiting upside. The stock's proximity to its 52-week high indicates technical overextension, raising caution for momentum investors. Additionally, the negative Return on Equity of -105.29% is a glaring red flag, questioning management's effectiveness in generating shareholder value.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$192.40

Institutional Ownership %

1-Year Beta

0.41

Insider Buying % (6 Mo)

Distance to 52-Week High

4.49%

Distance to 52-Week Low

23.08%

EARNINGS SURPRISE %

5.38%

50-DAY SMA

$178.27

200-DAY SMA

$167.23

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.